跳至主要内容
临床试验/NCT01952925
NCT01952925撤回不适用

Combined Atrial Fibrillation Ablation and Renal Artery Denervation for the Maintenance of Sinus Rhythm and Management of Resistant Hypertension

Oregon Health and Science University1 个研究点 分布在 1 个国家开始时间: 2019年3月最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
撤回
试验地点
1
主要终点
change in systolic blood pressure when measured at routine 1 and 3 month follow up appointments

研究概览

简要总结

The purpose of this study is to perform renal artery denervation at the same time as atrial fibrillation ablation. RA denervation may reduce blood pressure, increase the chances of a successful atrial fibrillation ablation, and decrease the number of medications required to control blood pressure.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 100 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Hypertensive patients scheduled for afib ablation
  • Patient taking one or more BP medication

排除标准

  • 未提供

研究组 & 干预措施

Combined afib ablation and RA denervation

Experimental

Patients with atrial fibrillation and resistant hypertension will be enrolled and undergo a single procedure consisting of pulmonary vein isolation and renal artery denervation.

干预措施: Renal Artery denervation (Procedure)

结局指标

主要结局

change in systolic blood pressure when measured at routine 1 and 3 month follow up appointments

时间窗: 1 to 3 months

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Charles Henrikson, MD

Associate Professor, Knight Cardiovascular Institute

Oregon Health and Science University

研究点 (1)

Loading locations...

相似试验